Neosaxitoxin in Rat Sciatic Block

Jay Scott Templin, Matthew C. Wylie, Joseph Kim, Katherine E. Kurgansky, Grzegorz Górski, John N. Kheir, David Zurakowski, Gabriel Corfas, Charles B. Berde

Anesthesiology · 2015 · 29 citations · 22 references

Concepts

Abstract

AbstractAbstract In rats, combination of Neosaxitoxin with bupivacaine for sciatic nerve block resulted in motor and sensory block, which was longer than either agent alone, and was up to 48 h when epinephrine was added. Histologic examination showed no evidence of neural toxicity, and intravenous injection of Neosaxitoxin resulted in cardiotoxicity with longer delays than bupivacaine. Background: Neosaxitoxin (NeoSTX) is a site-1 sodium channel blocker undergoing clinical trials as a prolonged-duration local anesthetic. Rat sciatic block and intravenous infusion models were used to assess efficacy and local and systemic toxicities for NeoSTX in saline ( NeoSTX-Saline ), bupivacaine ( Bup ), and their combination ( NeoSTX-Bup ). Exploratory studies evaluated the effects of addition of epinephrine to NeoSTX-Bup ( NeoSTX-Bup-Epi ). Methods: Rats received percutaneous sciatic blocks with escalating doses of NeoSTX-Saline or NeoSTX-Bup . Sensory-nocifensive block was assessed using modified hotplate and Von Frey filaments. Motor-proprioceptive function was assessed by extensor postural thrust. Nerves were examined histologically after 7 days and scored on the Estebe–Myers scale. Median lethal dose was estimated for NeoSTX-Saline and in combinations. Accidental intravenous overdose was simulated in isoflurane-anesthetized, spontaneously breathing rats receiving NeoSTX-Saline (n = 6), Bup (n = 7), or NeoSTX-Bup (n = 13), with respiratory, hemodynamic, and electrocardiographic endpoints. Additional groups received blocks with NeoSTX-Bup-Epi (n = 80). Investigators were blinded for behavioral and histologic studies. Results: NeoSTX-Bup produced more prolonged sensory and motor block compared with NeoSTX-Saline or Bup . NeoSTX-Bup-Epi further prolonged median time to near-complete recovery for 3 μg/kg NeoSTX-Bup (hotplate: 48 vs. 6 h, P < 0.001). With sciatic injections, addition of Bup did not worsen the systemic toxicity (median lethal dose) compared with NeoSTX-Saline . Intravenous NeoSTX-Saline infusion had significantly longer times to apnea, first arrhythmia, and asystole compared with Bup ( P < 0.001 for each). Histologic injury scores overall were low for all groups, with median scores of 0 (interquartile range, 0 to 0) on a 5-point scale. Conclusion: NeoSTX-Bup and NeoSTX-Bup-Epi hold promise for prolonged-duration local anesthesia.

References

22